{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:05:08Z","timestamp":1784653508646,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["advancesinpediatrics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Pediatrics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.yapd.2025.12.007","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:26:56Z","timestamp":1779362816000},"page":"295-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hidradenitis in Pediatrics"],"prefix":"10.1016","volume":"73","author":[{"given":"Soneet","family":"Dhillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Horneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Smogorzewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.yapd.2025.12.007_bib1","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jid.2018.04.001","article-title":"Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a Gender- and age-adjusted population analysis","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.yapd.2025.12.007_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaad.2014.11.017","article-title":"Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement","volume":"72","author":"Deckers","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.yapd.2025.12.007_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamadermatol.2020.5435","article-title":"Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients","volume":"157","author":"Liy-Wong","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/12034754211039993","article-title":"Pediatric hidradenitis suppurativa: a cross-sectional study on clinical features and treatment approaches","volume":"26","author":"Garcovich","year":"2022","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.yapd.2025.12.007_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5114\/ada.2024.144517","article-title":"Pediatric-onset hidradenitis suppurativa: a case series of 42 patients","volume":"41","author":"G\u00f3recka","year":"2024","journal-title":"Advances in Dermatology and Allergology\/Post\u0119py Dermatologii i Alergologii"},{"issue":"4","key":"10.1016\/j.yapd.2025.12.007_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13555-018-0264-z","article-title":"The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis","volume":"8","author":"Kimball","year":"2018","journal-title":"Dermatol Therapy"},{"issue":"3","key":"10.1016\/j.yapd.2025.12.007_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2020.09.072","article-title":"Quality of life in hidradenitis suppurativa: a cross-sectional study of a pediatric population","volume":"84","author":"McAndrew","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.yapd.2025.12.007_bib8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian hidradenitis suppurativa foundations","volume":"86","author":"Garg","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.yapd.2025.12.007_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaad.2018.02.067","article-title":"Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents","volume":"79","author":"Tiri","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.yapd.2025.12.007_bib10","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2015.07.051","article-title":"Hidradenitis suppurativa in the pediatric population","volume":"73","author":"Liy-Wong","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yapd.2025.12.007_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19681","article-title":"International hidradenitis suppurativa severity scoring system (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: a post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab","volume":"38","author":"Zouboulis","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.yapd.2025.12.007_bib12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.yapd.2025.12.007_bib13","first-page":"11","article-title":"Demographic features, clinical characteristics, and comorbid relation in hidradenitis suppurativa: a population-based study. Original Research","author":"Kaya","year":"2025","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaad.2019.08.034","article-title":"Association between obesity and hidradenitis suppurativa among children and adolescents: a population-based analysis in the United States","volume":"82","author":"Balgobind","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.yapd.2025.12.007_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pde.15746","article-title":"Obesity in pediatric hidradenitis suppurativa: a scoping review","volume":"42","author":"Mehta","year":"2025","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.yapd.2025.12.007_bib16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jid.2018.01.009","article-title":"Hidradenitis Suppurativa is associated with polycystic ovary syndrome: a population-based analysis in the United States","volume":"138","author":"Garg A","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.yapd.2025.12.007_bib17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2021.2865","article-title":"Differences between children and adults with hidradenitis suppurativa","volume":"157","author":"Hallock","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.yapd.2025.12.007_bib18","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamadermatol.2024.2613","article-title":"Smoking cessation and risk of hidradenitis suppurativa development","volume":"160","author":"Kim","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.yapd.2025.12.007_bib19","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamadermatol.2020.3630","article-title":"Contribution of genetics to the susceptibility to hidradenitis suppurativa in a large, cross-sectional Dutch twin cohort","volume":"156","author":"van Straalen","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.yapd.2025.12.007_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.det.2015.07.002","article-title":"The genetics of hidradenitis suppurativa","volume":"34","author":"Ingram","year":"2016","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.yapd.2025.12.007_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.yapd.2025.12.007_bib22","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jaad.2024.08.052","article-title":"Intrinsic factors in the pathogenesis of hidradenitis suppurativa: genetics, hormones, and the microbiome","volume":"91","author":"Frew","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.yapd.2025.12.007_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2133.2012.11174.x","article-title":"A novel splice site mutation in NCSTN underlies a Japanese family with hidradenitis suppurativa","volume":"168","author":"Nomura","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.yapd.2025.12.007_bib24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"\u03b3-Secretase variations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"Pink","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.yapd.2025.12.007_bib25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jamadermatol.2023.2217","article-title":"Genetic variants associated with hidradenitis suppurativa","volume":"159","author":"Sun","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/exd.14234","article-title":"Mechanical forces and Hidradenitis Suppurativa","volume":"30","author":"Boer","year":"2021","journal-title":"Exp Dermatol"},{"issue":"9","key":"10.1016\/j.yapd.2025.12.007_bib27","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jdv.15597","article-title":"The microbiome of tunnels in hidradenitis suppurativa patients","volume":"33","author":"Ring","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.yapd.2025.12.007_bib28","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/ijd.17892","article-title":"The microbiome in Hidradenitis Suppurativa tunnels: a systematic review","volume":"64","author":"Soto-Moreno","year":"2025","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/cix285","article-title":"The microbiological landscape of anaerobic infections in Hidradenitis Suppurativa: a prospective metagenomic study","volume":"65","author":"Guet-Revillet","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"508","key":"10.1016\/j.yapd.2025.12.007_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5908","article-title":"Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa","volume":"11","author":"Byrd","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.yapd.2025.12.007_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.yapd.2025.12.007_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15439","article-title":"Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: a retrospective study","volume":"35","author":"Molinelli","year":"2022","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.yapd.2025.12.007_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2020.01.007","article-title":"Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley stage 1 hidradenitis suppurativa: prospective short-term trial and 1-year follow-up in 28 consecutive patients","volume":"88","author":"Delage","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.yapd.2025.12.007_bib35","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-061049","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"151","author":"Cotton","year":"2023","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.yapd.2025.12.007_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for Hidradenitis Suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"issue":"10378","key":"10.1016\/j.yapd.2025.12.007_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.det.2021.12.004","article-title":"Hormonal treatment of acne and hidradenitis suppurativa in adolescent patients","volume":"40","author":"Svoboda","year":"2022","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.yapd.2025.12.007_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"2_suppl","key":"10.1016\/j.yapd.2025.12.007_bib40","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1177\/12034754221116115","article-title":"Practical guidelines for managing patients with Hidradenitis Suppurativa: an update","volume":"26","author":"Johnston","year":"2022","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","article-title":"Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review","volume":"18","author":"Layton","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.yapd.2025.12.007_bib42","first-page":"44","article-title":"Finasteride in Hidradenitis Suppurativa: a \"Male\" Therapy for a Predominantly \"Female\" disease","volume":"9","author":"Khandalavala","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"12","key":"10.1016\/j.yapd.2025.12.007_bib43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.36849\/JDD.2020.5447","article-title":"Metformin as adjunctive therapy for pediatric patients with Hidradenitis Suppurativa","volume":"19","author":"Moussa","year":"2020","journal-title":"J Drugs Dermatol JDD"},{"issue":"9","key":"10.1016\/j.yapd.2025.12.007_bib44","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s13555-024-01249-2","article-title":"A review of Hidradenitis Suppurativa in special populations: considerations in children, pregnant and breastfeeding women, and the elderly","volume":"14","author":"Chung","year":"2024","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.yapd.2025.12.007_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319830646","article-title":"Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms","volume":"10","author":"Frew","year":"2019","journal-title":"Therapeutic Advances in Chronic Disease"},{"issue":"6","key":"10.1016\/j.yapd.2025.12.007_bib46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2016.06.049","article-title":"Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series","volume":"75","author":"Riis","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.yapd.2025.12.007_bib47","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/pde.14955","article-title":"Surgical deroofing in pediatric patients with hidradenitis suppurativa","volume":"39","author":"Leszczynska","year":"2022","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.yapd.2025.12.007_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2020.04.117","article-title":"Treatment of hidradenitis suppurativa using a long-pulsed hair removal neodymium:yttrium-aluminium-garnet laser: a multicenter, prospective, randomized, intraindividual, comparative trial","volume":"84","author":"Naouri","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.yapd.2025.12.007_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa","volume":"14","author":"Von der Werth","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.yapd.2025.12.007_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bjd.19926","article-title":"Identifying triggers for hidradenitis suppurativa flare: a patient survey","volume":"185","author":"Thompson","year":"2021","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijwd.2020.02.005","article-title":"Special considerations for women with hidradenitis suppurativa","volume":"6","author":"Collier","year":"2020","journal-title":"Int J Women's Dermatol"},{"issue":"8","key":"10.1016\/j.yapd.2025.12.007_bib52","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/ijd.17101","article-title":"Evaluating dietary considerations in hidradenitis suppurativa: a critical examination of existing knowledge","volume":"63","author":"Vural","year":"2024","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.yapd.2025.12.007_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/nu11010057","article-title":"Role of nutrition and adherence to the mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease","volume":"11","author":"Barrea","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.yapd.2025.12.007_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/nu14030551","article-title":"Potential benefits of the mediterranean diet and physical activity in patients with hidradenitis suppurativa: a cross-sectional study in a Spanish population","volume":"14","author":"Lorite-Fuentes","year":"2022","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.yapd.2025.12.007_bib55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40257-018-0374-5","article-title":"Serum zinc levels in hidradenitis suppurativa: a case\u2013control study","volume":"19","author":"Poveda","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.yapd.2025.12.007_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jdermsci.2016.08.010","article-title":"Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa","volume":"84","author":"Hessam","year":"2016","journal-title":"J Dermatol Sci"},{"issue":"9","key":"10.1016\/j.yapd.2025.12.007_bib57","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s13555-025-01487-y","article-title":"Current treatments and future directions for Hidradenitis Suppurativa: a narrative review of completed and ongoing phase 3 clinical trials of biologic therapies","volume":"15","author":"Garg","year":"2025","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.yapd.2025.12.007_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000508787","article-title":"Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system","volume":"236","author":"Kokolakis","year":"2020","journal-title":"Dermatology"}],"container-title":["Advances in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310125000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310125000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:32:46Z","timestamp":1784651566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065310125000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0065310125000374"],"URL":"https:\/\/doi.org\/10.1016\/j.yapd.2025.12.007","relation":{},"ISSN":["0065-3101"],"issn-type":[{"value":"0065-3101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis in Pediatrics","name":"articletitle","label":"Article Title"},{"value":"Advances in Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yapd.2025.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}